Pulsenmore Partners with TLC Perinatal to Expand Home Ultrasound Services in the U.S.

Pulsenmore Partners with TLC Perinatal to Enhance Home Ultrasound Services in the U.S.

Pulsenmore Ltd., a leader in the field of home ultrasound technology, is making significant strides in the U.S. healthcare market through a new collaboration with TLC Perinatal PA, a reputable practice in Maryland specializing in maternal-fetal medicine. The partnership, announced on February 9, 2026, marks a vital milestone in Pulsenmore's mission to provide innovative telehealth solutions in prenatal care.

This latest initiative follows Pulsenmore's recent FDA clearance, enabling the company to deploy its Early Screening (ES) home ultrasound services into TLC Perinatal's care framework. The agreement will see patients utilizing Pulsenmore's ultrasound technology from the comfort of their homes, thereby complementing physician-directed care pathways that incorporate both telehealth and scheduled visits to the clinic.

A Shift Towards Patient-Centric Care

The engagement with TLC Perinatal reflects a broader trend within the U.S. healthcare landscape— a growing emphasis on patient-centered care. Maternal-fetal medicine practices are increasingly looking to adopt technologies that facilitate access to care beyond traditional clinical settings. Pulsenmore's innovative solution bridges this gap, merging telemedicine with home ultrasound capabilities, allowing for greater flexibility while ensuring that clinicians maintain oversight of their patients’ health conditions.

TLC Perinatal, led by Dr. Richard Broth, has developed a strong reputation for integrating advanced technologies in prenatal care. The practice handles around 2,000 pregnancies annually across its locations in Silver Spring and Germantown, Maryland. Under Dr. Broth's leadership, the adoption of Pulsenmore's ultrasound services will further enhance their evidence-based approach to patient care.

Enhancing Accessibility in Prenatal Care

Dr. Broth emphasized the significance of Pulsenmore's Home Ultrasound technology in transforming prenatal care. He stated that this collaboration exemplifies efforts to expand accessibility while ensuring patient convenience. The device aligns with the American College of Obstetricians and Gynecologists' (ACOG) 2025 Clinical Consensus by facilitating remote monitoring of fetal health, personalizing treatment delivery, accommodating patient preferences, and minimizing unnecessary office visits, all while striving to maintain or improve maternal and fetal health outcomes.

Dr. Elazar Sonnenschein, CEO of Pulsenmore, expressed enthusiasm about the company's entry into the U.S. market. He noted a strong engagement from practices prioritizing innovation and patient-centered care. Through the collaboration with TLC Perinatal, Pulsenmore aims to illustrate how home ultrasound can be seamlessly integrated into existing clinical workflows, providing patients with enhanced flexibility and continuous care.

About Pulsenmore

Pulsenmore Ltd. is committed to revolutionizing maternal health with its state-of-the-art home ultrasound technology, connected with healthcare providers and patients remotely. The company's innovative approach leverages advanced imaging and telemedicine to create a more personalized and accessible prenatal care experience. Interested individuals can explore more about Pulsenmore and its services at www.pulsenmore.com.

As Pulsenmore continues to broaden its reach and capabilities within the U.S. market, it represents a critical shift towards integrating technology in healthcare, particularly in the realm of prenatal care. This partnership with TLC Perinatal exemplifies the values of accessibility, innovation, and patient-centeredness that are shaping the future of maternal health.